| Record Information |
|---|
| Version | 1.0 |
|---|
| Creation date | 2010-04-08 22:09:52 UTC |
|---|
| Update date | 2019-11-26 03:05:35 UTC |
|---|
| Primary ID | FDB011856 |
|---|
| Secondary Accession Numbers | Not Available |
|---|
| Chemical Information |
|---|
| FooDB Name | L-Histidine |
|---|
| Description | Flavouring ingredient; dietary supplement, nutrient
Histidine (abbreviated as His or H) is one of the 20 standard amino acids present in proteins. Nutritionally, histidine is considered an essential amino acid in human infants. After reaching several years of age, humans begin to synthesize it and it thus becomes a non-essential amino acid. Its codons are CAU and CAC.; Is found abundantly in hemoglobin; The amino acid is a precursor for histamine and carnosine biosynthesis.; The imidazole sidechain of histidine is a common coordinating ligand in metalloproteins and is a part of catalytic sites in certain enzymes. In catalytic triads, the basic nitrogen of histidine is used to abstract a proton from serine, threonine or cysteine to activate it as a nucleophile. In a histidine proton shuttle, histidine is used to quickly shuttle protons, it can do this by abstracting a proton with its basic nitrogen to make a positively-charged intermediate and then use another molecule, a buffer, to extract the proton from its acidic nitrogen. In carbonic anhydrases, a histidine proton shuttle is utilized to rapidly shuttle protons away from a zinc-bound water molecule to quickly regenerate the active form of the enzyme.; histidine is an essential amino acid for infants but not adults. Infants four to six months old require 33 mg/kg of histidine. It is not clear how adults make small amounts of histidine, and dietary sources probably account for most of the histidine in the body. Inborn errors of histidine metabolism exist and are marked by increased histidine levels in the blood. Elevated blood histidine is accompanied by a wide range of symptoms, from mental and physical retardation to poor intellectual functioning, emotional instability, tremor, ataxia and psychosis. histidine in medical therapies has its most promising trials in rheumatoid arthritis where up to 4.5 g daily have been used effectively in severely affected patients. Arthritis patients have been found to have low serum histidine levels, apparently because of too-rapid removal of histidine from their blood. histidine and other imidazole compounds have anti-inflammatory properties. histidine may accomplish this function through a complex interaction with threonine or cysteine and possibly copper. However, copper is usually elevated in rheumatoid arthritis patients and worsens the disease. Other patients besides arthritis patients that have been found to be low in serum histidine are those with chronic renal failure. histidine has been claimed to have been useful in hypertension because of its vasodilatory effects. Claims of its use to improve libido and counteract allergy are without proof at present. histidine may have many other possible functions because it is the precursor of the ubiquitous neurohormone-neurotransmitter histamine. histidine increases histamine in the blood and probably in the brain. Low blood histamine with low serum histidine occurs in rheumatoid arthritis patients. Low blood histamine also occurs in some manic, schizophrenic, high copper and hyperactive groups of psychiatric patients. histidine is a useful therapy in all low histamine patients. ( http://www.dcnutrition.com ). L-Histidine is found in many foods, some of which are lemon verbena, sparkleberry, rowanberry, and walleye. |
|---|
| CAS Number | 71-00-1 |
|---|
| Structure | |
|---|
| Synonyms | | Synonym | Source |
|---|
| alpha-Amino-1H-imidazole-4-propionic acid | ChEBI | | DL-Histidine | ChEBI | | Histidin | ChEBI | | Histidina | ChEBI | | a-Amino-1H-imidazole-4-propionate | Generator | | a-Amino-1H-imidazole-4-propionic acid | Generator | | alpha-Amino-1H-imidazole-4-propionate | Generator | | Α-amino-1H-imidazole-4-propionate | Generator | | Α-amino-1H-imidazole-4-propionic acid | Generator | | (2S)-2-amino-3-(1H-imidazol-4-yl)propanoic acid | biospider | | (2S)-2-amino-3-(3H-imidazol-4-yl)propanoic acid | biospider | | (l)-histidine | biospider | | (S)-1H-Imidazole-4-alanine | biospider | | (S)-2-Amino-3-(4-imidazolyl)propionic acid | biospider | | (S)-2-amino-3-(4-Imidazolyl)propionsaeure | HMDB | | (S)-4-(2-Amino-2-carboxyethyl)imidazole | biospider | | (S)-a-Amino-1H-imidazole-4-propanoate | biospider | | (S)-a-Amino-1H-imidazole-4-propanoic acid | biospider | | (S)-a-amino-1H-Imidazole-4-propionate | Generator | | (S)-a-amino-1H-Imidazole-4-propionic acid | Generator | | (S)-alpha-Amino-1H-imidazole-4-propanoate | biospider | | (S)-alpha-Amino-1H-imidazole-4-propanoic acid | biospider | | (S)-alpha-Amino-1H-imidazole-4-propionate | biospider | | (S)-alpha-Amino-1H-imidazole-4-propionic acid | biospider | | (s)-histidine | biospider | | (S)-α-amino-1H-imidazole-4-propanoate | Generator | | (S)-α-amino-1H-imidazole-4-propanoic acid | Generator | | (S)-α-amino-1H-imidazole-4-propionate | Generator | | (S)-α-amino-1H-imidazole-4-propionic acid | Generator | | (S)1H-Imidazole-4-alanine | biospider | | 1H-Imidazole-4-alanine, (S)- | biospider | | 1H-Imidazole-4-propanoic acid, α-amino-, (S)- | biospider | | 1H-Imidazole-4-propanoic acid, alpha-amino-, (S)- | biospider | | 3-(1H-imidazol-4-yl)-L-Alanine | biospider | | 4-(2-Amino-2-carboxyethyl)imidazole | biospider | | alpha-Amino-1H-imidazole-4-propionic acid, (S)- | biospider | | alpha-Amino-4(or 5)-imidazolepropionic acid | biospider | | amino-1H-imidazole-4-propanoate | biospider | | amino-1H-imidazole-4-propanoic acid | biospider | | amino-4-imidazoleproprionate | biospider | | amino-4-imidazoleproprionic acid | biospider | | FEMA 3694 | db_source | | Glyoxaline-5-alanine | biospider | | H | ChEBI | | His | ChEBI | | HISTIDINE | ChEBI | | Histidine (usp/inn) | biospider | | Histidine (van) | biospider | | Histidine [usan:inn] | biospider | | Histidine, INN, USAN; L-form | db_source | | Histidine, l- | biospider | | L-(-)-histidine | biospider | | L-Alanine, 3-(1H-imidazol-4-yl)- | biospider | | L-beta-(4-Imidazolyl)-alpha-alanin | biospider | | L-beta-(4-Imidazolyl)alanin | biospider | | L-histidin | biospider | | L-Histidine | biospider | | S-histidine | biospider |
|
|---|
| Predicted Properties | |
|---|
| Chemical Formula | C6H9N3O2 |
|---|
| IUPAC name | 2-amino-3-(1H-imidazol-5-yl)propanoic acid |
|---|
| InChI Identifier | InChI=1S/C6H9N3O2/c7-5(6(10)11)1-4-2-8-3-9-4/h2-3,5H,1,7H2,(H,8,9)(H,10,11) |
|---|
| InChI Key | HNDVDQJCIGZPNO-UHFFFAOYSA-N |
|---|
| Isomeric SMILES | NC(CC1=CN=CN1)C(O)=O |
|---|
| Average Molecular Weight | 155.1546 |
|---|
| Monoisotopic Molecular Weight | 155.069476547 |
|---|
| Classification |
|---|
| Description | Belongs to the class of organic compounds known as histidine and derivatives. Histidine and derivatives are compounds containing cysteine or a derivative thereof resulting from reaction of cysteine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organic acids and derivatives |
|---|
| Class | Carboxylic acids and derivatives |
|---|
| Sub Class | Amino acids, peptides, and analogues |
|---|
| Direct Parent | Histidine and derivatives |
|---|
| Alternative Parents | |
|---|
| Substituents | - Histidine or derivatives
- Alpha-amino acid
- Imidazolyl carboxylic acid derivative
- Aralkylamine
- Azole
- Imidazole
- Heteroaromatic compound
- Amino acid
- Azacycle
- Organoheterocyclic compound
- Monocarboxylic acid or derivatives
- Carboxylic acid
- Organic nitrogen compound
- Primary amine
- Organooxygen compound
- Organonitrogen compound
- Primary aliphatic amine
- Organic oxide
- Organopnictogen compound
- Carbonyl group
- Organic oxygen compound
- Amine
- Hydrocarbon derivative
- Aromatic heteromonocyclic compound
|
|---|
| Molecular Framework | Aromatic heteromonocyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Ontology | No ontology term |
|---|
| Physico-Chemical Properties |
|---|
| Physico-Chemical Properties - Experimental | | Property | Value | Reference |
|---|
| Physical state | Solid | |
|---|
| Physical Description | Not Available | |
|---|
| Mass Composition | C 46.45%; H 5.85%; N 27.08%; O 20.62% | DFC |
|---|
| Melting Point | Mp 277° dec. | DFC |
|---|
| Boiling Point | Not Available | |
|---|
| Experimental Water Solubility | 45.6 mg/mL at 25 oC | YALKOWSKY,SH & DANNENFELSER,RM (1992) |
|---|
| Experimental logP | -3.32 | CHMELIK,J ET AL. (1991) |
|---|
| Experimental pKa | 2.76 | |
|---|
| Isoelectric point | Not Available | |
|---|
| Charge | Not Available | |
|---|
| Optical Rotation | [a]25D +18.3 (+11.8) (5M HCl) | DFC |
|---|
| Spectroscopic UV Data | Not Available | |
|---|
| Density | Not Available | |
|---|
| Refractive Index | Not Available | |
|---|
|
|---|
| Spectra |
|---|
| Spectra | |
|---|
| EI-MS/GC-MS | | Type | Description | Splash Key | View |
|---|
| EI-MS | Mass Spectrum (Electron Ionization) | splash10-001i-9100000000-ae0a0b81669663b3b4a5 | 2014-09-20 | View Spectrum | | Predicted GC-MS | L-Histidine, non-derivatized, Predicted GC-MS Spectrum - 70eV, Positive | splash10-001i-9400000000-5e6963983298535b27d8 | Spectrum | | Predicted GC-MS | L-Histidine, non-derivatized, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum | | Predicted GC-MS | L-Histidine, TMS_1_1, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum | | Predicted GC-MS | L-Histidine, TMS_1_2, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum | | Predicted GC-MS | L-Histidine, TMS_1_3, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum | | Predicted GC-MS | L-Histidine, TBDMS_1_1, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum | | Predicted GC-MS | L-Histidine, TBDMS_1_2, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum | | Predicted GC-MS | L-Histidine, TBDMS_1_3, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum |
|
|---|
| MS/MS | | Type | Description | Splash Key | View |
|---|
| MS/MS | LC-MS/MS Spectrum - 45V, Positive | splash10-053r-9000000000-1478106116309658fadd | 2021-09-20 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - 35V, Positive | splash10-001i-9200000000-c7bde7fc68c95b650666 | 2021-09-20 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - 15V, Positive | splash10-0bt9-0900000000-5ae6a574e7140a379bbd | 2021-09-20 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - 25V, Positive | splash10-03di-4900000000-1236c6813216a3650ccc | 2021-09-20 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - 25V, Positive | splash10-03di-3900000000-7eed8a793aebb339a1a1 | 2021-09-20 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - 45V, Positive | splash10-053r-9000000000-2dd5486f7b3241685315 | 2021-09-20 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - 20V, Negative | splash10-0gw0-0900000000-a0cbbe99d0c71d0ff5c7 | 2021-09-20 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - 10V, Negative | splash10-0udi-0900000000-39864028be32b684b6b8 | 2021-09-20 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - 10V, Positive | splash10-03di-0900000000-c792e4d6040e598120d3 | 2021-09-20 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-08g0-0900000000-9089f7d82f3446b94c4f | 2018-04-06 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-03di-7900000000-717ec4c802609a81cf53 | 2018-04-06 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-0f89-9000000000-03526fc1a092a64548b9 | 2018-04-06 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-0udi-1900000000-b23127c1801c4cf851ed | 2018-04-06 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-0ul9-8900000000-c5317c32047bfd386dae | 2018-04-06 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-007o-9000000000-e9c8ee81851c24c3bc0d | 2018-04-06 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-08fr-0900000000-2c5b01f968746b87ab67 | 2021-10-12 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-03dl-6900000000-ab46f486b2b76d433d32 | 2021-10-12 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-053u-9000000000-e3d5332f624d684d2d2a | 2021-10-12 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-0udr-1900000000-4ca598739f604c4fdd39 | 2021-10-12 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-0006-9300000000-4ce447c349d8c431928b | 2021-10-12 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-00kf-9000000000-cafb1c651f51cab7cf44 | 2021-10-12 | View Spectrum |
|
|---|
| NMR | | Type | Description | | View |
|---|
| 1D NMR | 13C NMR Spectrum (1D, 22.53 MHz, D2O, experimental) | | Spectrum |
|
|---|
| External Links |
|---|
| ChemSpider ID | 6038 |
|---|
| ChEMBL ID | CHEMBL17962 |
|---|
| KEGG Compound ID | C00135 |
|---|
| Pubchem Compound ID | 6274 |
|---|
| Pubchem Substance ID | Not Available |
|---|
| ChEBI ID | 15971 |
|---|
| Phenol-Explorer ID | Not Available |
|---|
| DrugBank ID | DB00117 |
|---|
| HMDB ID | HMDB00177 |
|---|
| CRC / DFC (Dictionary of Food Compounds) ID | HBB51-Y:HBB61-B |
|---|
| EAFUS ID | 1701 |
|---|
| Dr. Duke ID | L-HISTIDINE|HISTIDINE |
|---|
| BIGG ID | 33985 |
|---|
| KNApSAcK ID | C00001363 |
|---|
| HET ID | 1KAH |
|---|
| Food Biomarker Ontology | Not Available |
|---|
| VMH ID | Not Available |
|---|
| Flavornet ID | Not Available |
|---|
| GoodScent ID | rw1037461 |
|---|
| SuperScent ID | Not Available |
|---|
| Wikipedia ID | L-Histidine |
|---|
| Phenol-Explorer Metabolite ID | Not Available |
|---|
| Duplicate IDS | Not Available |
|---|
| Old DFC IDS | Not Available |
|---|
| Associated Foods |
|---|
| Food | Content Range | Average | Reference |
|---|
| Food | | | Reference |
|---|
|
| Biological Effects and Interactions |
|---|
| Health Effects / Bioactivities | | Descriptor | ID | Definition | Reference |
|---|
| Anti-arteriosclerotic | 38070 | An agent that prevents or slows the progression of arteriosclerosis, a condition characterized by the hardening and narrowing of arteries. It reduces the formation of plaques, lowering the risk of cardiovascular disease. Therapeutically, it is used to manage atherosclerosis, hyperlipidemia, and hypertension, ultimately reducing the risk of heart attacks and strokes. | DUKE | | Anti nephritic | 52217 | An agent that reduces kidney inflammation, commonly used to manage nephritis and other kidney disorders, helping to prevent kidney damage and promote renal health. | DUKE | | Anti-oxidant | 22586 | An agent that neutralizes free radicals, reducing oxidative stress and cell damage. Its biological role involves protecting cells from harm, and it has therapeutic applications in managing chronic diseases, such as cancer, diabetes, and neurodegenerative disorders, with key medical uses including anti-aging, anti-inflammatory, and cardio protective effects. | DUKE | | Anti ulcer | 49201 | An agent that reduces stomach acid and protects the mucous lining, preventing ulcer formation. It is used to treat conditions like gastroesophageal reflux disease (GERD), peptic ulcers, and Zollinger-Ellison syndrome, promoting healing and relieving symptoms. | DUKE | | Anti uremic | | An agent that reduces urea levels in the body, mitigating kidney injury or failure. It plays a biological role in regulating nitrogen waste, and has therapeutic applications in managing uremia, a condition characterized by elevated urea levels. Key medical uses include treating kidney disease, acute kidney injury, and end-stage renal disease. | DUKE | | Essential | | A substance crucial for a specific biological process or condition, playing a vital role in maintaining health. Therapeutically, essentials are used to prevent or treat deficiencies, with key medical applications including nutrition, hormone regulation, and disease prevention, ultimately supporting overall well-being. | DUKE | | Oxidant | 63248 | A chemical that readily accepts electrons, often causing cellular damage. Biologically, oxidants play a role in immune response and cell signaling. Therapeutically, oxidants are used in cancer treatment, such as photodynamic therapy, and as disinfectants. Medically, they are used to treat conditions like acne, wounds, and certain infections, due to their ability to kill bacteria and promote healing. | DUKE |
|
|---|
| Enzymes | | Name | Gene Name | UniProt ID |
|---|
| Aromatic-L-amino-acid decarboxylase | DDC | P20711 | | Histidine decarboxylase | HDC | P19113 | | Histidine ammonia-lyase | HAL | P42357 | | Probable histidine--tRNA ligase, mitochondrial | HARS2 | P49590 | | Histidine--tRNA ligase, cytoplasmic | HARS | P12081 |
|
|---|
| Pathways | |
|---|
| Metabolism | Not Available |
|---|
| Biosynthesis | Not Available |
|---|
| Organoleptic Properties |
|---|
| Flavours | | Flavor | Citations |
|---|
| odorless |
- The Good Scents Company (2009). Flavor and fragrance information catalog. <http://www.thegoodscentscompany.com/allprod.html> Accessed 15.10.23.
| | bitter |
- Ayana Wiener, Marina Shudler, Anat Levit, Masha Y. Niv. BitterDB: a database of bitter compounds. Nucleic Acids Res 2012, 40(Database issue):D413-419. DOI:10.1093/nar/gkr755
|
|
|---|
| Files |
|---|
| MSDS | show |
|---|
| References |
|---|
| Synthesis Reference | Not Available |
|---|
| General Reference | Not Available |
|---|
| Content Reference | — Saxholt, E., et al. 'Danish food composition databank, revision 7.' Department of Nutrition, National Food Institute, Technical University of Denmark (2008). — U.S. Department of Agriculture, Agricultural Research Service. 2008. USDA National Nutrient Database for Standard Reference, Release 21. Nutrient Data Laboratory Home Page. — Duke, James. 'Dr. Duke's Phytochemical and Ethnobotanical Databases. United States Department of Agriculture.' Agricultural Research Service, Accessed April 27 (2004). — Shinbo, Y., et al. 'KNApSAcK: a comprehensive species-metabolite relationship database.' Plant Metabolomics. Springer Berlin Heidelberg, 2006. 165-181.
|
|---|